251 DeKalb Earns Keystone Trilogy Award for Fourth Consecutive Year
Keystone Award winners are determined through independent evaluations conducted from the perspective of a prospective resident. Each community is assessed on a 594-point scale covering the leasing experience, maintenance standards and curb appeal, and is compared only with communities of similar size, age, type and rent.
"These awards represent the daily commitment, teamwork and pride our teams bring to our communities and residents," said Brett Goldenhorn, senior vice president of operations at Lindy Communities.
Situated on 26 acres at the highest point in
Residents cite the community's service as a defining strength. "The management and maintenance teams are consistently responsive, professional, and helpful. … It's refreshing to feel heard and valued as a resident," one current resident wrote.
For more information or to schedule a tour, visit 251dekalb.com or call 844-665-3547.
About Lindy Communities
Lindy Communities is a fourth-generation, family-owned real estate company that has been creating apartment homes in the Philadelphia region since 1939. Headquartered in Jenkintown, Pennsylvania, the company owns and operates 50 apartment communities across Pennsylvania, Florida, Ohio, Illinois and Tennessee, including more than 6,500 apartments in the Philadelphia region. Lindy's approach emphasizes environmental responsibility and community engagement, including its Fiesta Schoolyards initiative, which brings play spaces to Philadelphia public schools and parks. For more information, visit lindyproperty.com.
For media inquiries, contact Abby Gross at [email protected].
View original content to download multimedia:https://www.prnewswire.com/news-releases/251-dekalb-earns-keystone-trilogy-award-for-fourth-consecutive-year-302916229.html
SOURCE Lindy Communities
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westlake Securities Advises Watermark Commercial Contractors on Chicago Atlantic Financing for Acquisition of Val-Chris Investments
- Narcolepsy Pipeline Outlook 2026: Oral, Injectable, and Novel Delivery Candidates Advancing Through Clinical Trials | Novartis, Shionogi Inc., Takeda, Avadel Pharma, Harmony Biosciences, Jazz Pharma
- Tint World Included on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share